SCHEMBL5773517

SCHEMBL5773517

Cc1c(O)cc2cc(C(O)CN3CCOCC3)oc2c1C

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.42
HSD17B10 Q99714 3/20 0.40
MAPT P10636 2/20 0.40
THRB P10828 1/20 0.40
ALOX15 P16050 1/20 0.40
ALDH1A1 P00352 3/20 0.39
USP2 O75604 1/20 0.39
KMT2A Q03164 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
MEN1 O00255 1/20 0.37
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP2D6 P10635 1/20 0.35
GAA P10253 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5769835 0.74 ALDH1A1 (0.47) KDM4EHSD17B10MAPTALOX15ALDH1A1
SCHEMBL7248869 0.73 CASP1 (0.34) HSD17B10MAPTALOX15ALDH1A1KMT2A
SCHEMBL5772217 0.69 RAB9A (0.49) ALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL17385603 0.66 KDM4E (0.63) KDM4EHSD17B10MAPTTHRBALDH1A1
SCHEMBL31070282 0.64 CYP2C9 (0.57) KDM4EHSD17B10MAPTALOX15ALDH1A1
SCHEMBL31419975 0.63 KDM4E (0.73) KDM4EALDH1A1USP2KMT2AMEN1
SCHEMBL15274496 0.63 KDM4E (0.55) KDM4EHSD17B10MAPTTHRBALOX15
SCHEMBL12781757 0.63 KDM4E (0.62) KDM4EHSD17B10MAPTALDH1A1USP2
SCHEMBL5773555 0.62 KDM4E (0.32) KDM4EMAPTALDH1A1L3MBTL1
SCHEMBL23610052 0.61 KDM4E (0.71) KDM4EHSD17B10KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1472241-A4 CYTOPROTECTIVE BENZOFURAN DERIVATIVES GALILEO PHARMACEUTICALS INC (US) 2005-06-29 EP claimed
EP-1472241-A1 CYTOPROTECTIVE BENZOFURAN DERIVATIVES Galileo Pharmaceuticals, Inc. (US) 2004-11-03 EP claimed
WO-2003066618-A1 CYTOPROTECTIVE BENZOFURAN DERIVATIVES GALILEO PHARMACEUTICALS, INC. (US) 2003-08-14 WO claimed
US-7078541-B2 Benzofuran derivatives GALILEO PHARMACEUTICALS, INC. (US) 2006-07-18 US disclosed
EP-1472241-A4 CYTOPROTECTIVE BENZOFURAN DERIVATIVES GALILEO PHARMACEUTICALS INC (US) 2005-06-29 EP disclosed
WO-2005027900-A1 BENZOFURAN DERIVATIVES GALILEO PHARMACEUTICALS, INC. (US) 2005-03-31 WO disclosed
EP-1472241-A1 CYTOPROTECTIVE BENZOFURAN DERIVATIVES Galileo Pharmaceuticals, Inc. (US) 2004-11-03 EP disclosed
US-20040063975-A1 Benzofuran derivatives EDISON PHARMACEUTICALS, INC. 2004-04-01 US disclosed
US-6653346-B1 Amtiischemic and antiinflammatory agents GALILEO PHARMACEUTICALS, INC. 2003-11-25 US disclosed
WO-2003066618-A1 CYTOPROTECTIVE BENZOFURAN DERIVATIVES GALILEO PHARMACEUTICALS, INC. (US) 2003-08-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063975-A1 Benzofuran derivatives NDUFAB1, AIFM1, NDUFAF1 KDM4E 1972/4885HSD17B10 672/4885MAPT 278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.